Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets

Regulatory Peptides

Volumn 111, Issue 1-3, 2003, Pages 55-60

  Åkesson, Björn ^a   Panagiotidis, Georgios ^a   Westermark, Per ^b   Lundquist, Ingmar ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cholinergic agonist; Glucose; Islet secretory mechanisms; L Arginine; Phosphodiesterase inhibition

Indexed keywords

AMYLIN; ARGININE; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE INHIBITOR;

ARTICLE; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; GLUCAGON RELEASE; HORMONE RELEASE; INCUBATION TIME; INSULIN RELEASE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; STIMULATION;

1-METHYL-3-ISOBUTYLXANTHINE; AMYLOID; ANIMALS; ARGININE; CARBACHOL; CHOLINERGIC AGONISTS; CULTURE MEDIA; FEMALE; GLUCAGON; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; MICE; PHOSPHODIESTERASE INHIBITORS;

EID: 0037471369     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00252-5     Document Type: Article

References (41)

1. Westermark P. Islet amyloid polypeptide and amyloid in the islets of Langerhans. Leslie R.D.G., Robbins D. Diabetes: clinical science in practice. 1995;189-199 Cambridge Univ. Press, Cambridge.
2. Janson J., Soeller W.C., Roche P.C., Nelson R.T., Torchia A.J., Kreutter D.K.et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc. Natl. Acad. Sci. U. S. A. 93:1996;7283-7288.
3. Verchere C.B., D'Alessio D.A., Palmiter R.D., Weir G.C., Bonner-Weir S., Baskin D.G.et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc. Natl. Acad. Sci. U. S. A. 93:1996;3492-3496.
4. Höppener J.W.M., Oosterwijk C., Nieuwenhuis M.G., Posthuma G., Thijssen J.H.H., Vroom T.M.et al. Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia. 42:1999;427-434.
5. Westermark G.T., Gebre-Medhin S., Steiner D.F., Westermark P. Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol. Med. 6:2000;998-1007.
6. Leighton M., Cooper G.J.S. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature. 335:1998;632-635.
7. Bryer-Ash M., Follet L., Hodges N., Wimalawansa S. Amylin-mediated reduction in insulin sensitivity corresponds to reduced insulin receptor kinase activity in the rat in vivo. Metabolism. 44:1995;705-711.
8. Castle A.L., Kuo C.-H., Han D.-H., Ivy J.L. Amylin-mediated inhibition of insulin-stimulated glucose transport in skeletal muscle. Am. J. Physiol. 275:1998;E531-E536.
9. Degano P., Silvestre R.A., Salas M., Peiro E., Marco J. Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul. Pept. 43:1993;91-96.
10. Wang Z.L., Bennet W.M., Ghatei M.A., Byfield P.G., Smith D.M., Bloom S.R. Influence of islet amyloid polypeptide on insulin release from perfused rat islets. Diabetes. 42:1993;330-335.
11. Wang F., Westermark G., Gasslander T., Permert J. Effect of islet amyloid polypeptide on somatostatin inhibition of insulin secretion from isolated rat pancreatic islets. Regul. Pept. 72:1997;61-67.
12. Gebre-Medhin S., Mulder H., Pekny M., Zhang Y.-Z., Törnell J., Westermark P.et al. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem. Biophys. Res. Commun. 250:1998;271-277.
13. Wang F., Permert J., Östenson C.-G. Islet amyloid polypeptide regulates multiple steps in stimulus-secretion coupling of beta cells in rat pancreatic islets. Pancreas. 20:2000;264-269.
14. Leckström A., Östenson C.-G., Efendic S., Arnelo U., Permert J., Lundquist I.et al. Increased storage and secretion of islet amyloid polypeptide relative to insulin in the spontaneously diabetic GK rat. Pancreas. 13:1996;259-267.
15. Leckström A., Lundquist I., Ma Z., Westermark P. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas. 18:1999;266-273.
16. Panagiotidis G., Salehi A., Westermark P., Lundquist I. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon insulin and glucose in the mouse. Diabetes Res. Clin. Pract. 18:1992;167-171.
17. Åkesson B., Panagiotidis G., Westermark P., Lundquist I. The nature of the stimulus determines the effects of IAPP on islet hormone release. Pharmacol. Toxicol. (Suppl. IV):1995;76.
18. Gedulin B.R., Rink T.J., Young A.A. Dose-response for glucagonostatic effect of amylin in rats. Metabolism. 46:1997;67-70.
19. Wang F., Adrian T.E., Westermark G.T., Ding X., Gasslander T., Permert J. Islet amyloid polypeptide tonally inhibits β-, α-, and δ-cell secretion in isolated rat pancreatic islets. Am. J. Physiol. 276:1999;E19-E24.
20. Samols E., Stagner J.I., Ewart R.B.L., Marks V. The order of islet microvascular cellular perfusion is B→A→D in the perfused rat pancreas. J. Clin. Invest. 82:1988;350-353.
21. Bonner-Weir S., Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes. 31:1982;883-889.
22. Gotoh M.T.T., Maki T., Kiyoizumi T., Satomi S., Monaco A.P. An improved method for isolation of mouse pancreatic islets. Transplantation. 40:1985;437-438.
23. Panagiotidis G., Alm P., Lundquist I. Inhibition of nitric oxide synthase increases arginine-induced insulin release. Eur. J. Pharmacol. 229:1992;277-278.
24. Heding L.A. A simplified insulin radioimmunoassay method. Donato L., Milhaud G., Sirchis J. Labelled proteins in tracer studies. 1966;345-350 EURATOM, Brussels.
25. Ahrén B., Lundquist I. Glucagon immunoreactivity in plasma from normal and dystrophic mice. Diabetologia. 22:1982;258-263.
26. Gao Z.-Y., Gérard M., Henquin J.-C. Glucose- and concentration-dependence of vasopressin-induced hormone release by mouse pancreatic islets. Regul. Pept. 38:1992;89-98.
27. Åkesson B., Henningsson R., Salehi A., Lundquist I. Islet constitutive nitric oxide synthase and glucose regulation of insulin release in mice. J. Endocrinol. 163:1999;39-48.
28. Fehmann H.C., Weber V., Göke R., Göke B., Arnold R. Cosecretion of amylin and insulin from isolated rat pancreas. FEBS Lett. 262:1990;279-281.
29. Stridsberg M., Sandler S., Wilander E. Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of β-cell function. Regul. Pept. 45:1993;363-370.
30. Inoue K., Hiramatsu S., Hisatomi A., Umeda F., Nawata H. Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging. Metabolism. 42:1993;654-658.
31. Fehmann H.C., Weber V., Göke R., Göke B., Eissele R., Arnold R. Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas. Biochem. Biophys. Res. Commun. 167:1990;1102-1108.
32. Rorsman P., Ashcroft F.M., Berggren P.-O. Regulation of glucagon release from pancreatic A-cells. Biochem. Pharmacol. 41:1991;1781-1790.
33. Cooper G.J.S. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr. Rev. 15:1994;163.
34. Nagamatsu S., Carroll R.J., Grodsky G.M., Steiner D.F. Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets. Diabetes. 39:1990;871-874.
35. Silvestre R.A., Rodríguez-Gallardo J., Jodka C., Parkes D.G., Pittner R.A., Young A.A.et al. Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas. Am. J. Physiol. 280:2001;E443-E449.
36. Lundquist I., Fanska R., Grodsky G.M. Direct calcium-stimulated release of glucagon from the isolated perfused rat pancreas and the effect of chemical sympathectomy. Endocrinology. 98:1976;815-818.
37. Lundquist I., Fanska R., Grodsky G.M. Interaction of calcium and glucose on glucagon secretion. Endocrinology. 99:1976;1304-1312.
38. Wagoner P.K., Chen C., Worley J.F., Dukes I.D., Oxford G.S. Amylin modulates β-cell glucose sensing via effects on stimulus-secretion coupling. Proc. Natl. Acad. Sci. U. S. A. 90:1993;9145-9149.
39. Fürsinn C., Leuvenink H., Roden M., Nowotny P., Schneider B., Rohac M.et al. Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am. J. Physiol. 267:1994;E300-E305.
40. Tilakaratne N., Christopoulos G., Zume E.T., Foord S.M., Sexton P.M. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J. Pharmacol. Exp. Ther. 294:2000;61-72.
41. Martinez A., Kapas S., Miller M.J., Ward Y., Cuttitta F. Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide, and amylin in pancreatic beta-cells. Endocrinology. 141:2000;406-411.